FailedFiled Nov 25, 2025
Sponsor: Regina Birdsell (R)
Latest Action
Interim Study Report: Not Recommended for Future Legislation 10/15/2026 (Vote 11-0; )
Oct 19, 2026
Summary
SB 606 would have the state examine how health insurers cover biomarker tests, which are used to guide medical treatment. The measure could affect patients who need these tests and the insurers that pay for them. The Senate passed the bill and sent it to an interim study for further analysis.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when SB 606 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 606 freeOr ask your AI assistant about SB 606 directly:
Add to Claude, ChatGPT or Cursor